Status:

RECRUITING

Post-Intensive Care Transitional Care, Rehabilitation, and Family-Support

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

Agency for Healthcare Research and Quality (AHRQ)

Conditions:

Intensive Care Unit Syndrome

Disabilities Multiple

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

The goal of this randomized control trial is to test an intervention designed to improve patient and family outcomes after critical illness compared to usual care. The intervention, called Post-Intens...

Detailed Description

Each year in the United States, over 3 million people survive critical illness only to experience long-term physical, cognitive, and psychological functional impairments that contribute to ongoing hea...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • In order to be eligible to participate in this study, a patient must meet all of the following criteria:
  • All genders; Age ≥ 50
  • Admission to the hospital from home/independent living
  • Receive treatment in an ICU for ≥ 48 hours
  • At least some risk of ongoing functional impairment, measured as Activity Measures for Post-Acute Care (AMPAC) \< 24, Highest Level Mobility (HLM) \< 8, Intensive Care Delirium Screening Checklist (ICDSC) \> 2, Significant mental health impairment (major depression, generalized anxiety, PTSD, substance use disorder)
  • Provider or e-prognosis that they are reasonably likely to be alive in 12 months (answers no to "Would you be surprised if this person were alive in 12 months?' or eprognosis risk of 1-year mortality \<= 35%
  • Willingness to adhere to the PIC-TRFS regimen.
  • Provision of signed and dated informed consent form
  • In order to be eligible to participate in this study, a family caregiver must meet all of the following criteria:
  • All genders; Age ≥ 18 years old
  • In the survivor's social network
  • Planning to provide at least some in-home support for the survivor after discharge
  • Willingness to adhere to the PIC-TRFS regimen
  • Provision of signed and dated informed consent form
  • In order to be eligible for randomization, dyads must meet all of the following criteria:
  • Completion of at least the following elements of the Run-In:
  • Patient: demographics, social needs screening tool, symptom bother scale, brief health literacy screening tool, past medical history, baseline function (Katz, Lawton, and caregiver-reported IQCODE), health priorities \& goals, discharge information
  • Caregiver: demographics, social needs screening tool, caregiver needs screening, brief health literacy screening, family caregiver training
  • Discharge to home/independent living
  • Exclusion criteria
  • Survivors will be excluded if any of the following apply:
  • They lack a family caregiver willing to participate;
  • They have a chronic condition for which they are already receiving dedicated transitional care services (e.g., post-cardiac arrest, transplant, TAVR, etc)
  • They have chronic functional dependency without potential to increase participation in meaningful activity
  • They reside outside of Pennsylvania (interventionists are only licensed to practice here)
  • They are unable to participate in English
  • A family caregiver who meets any of the following criteria will be excluded from participation in this study:
  • 1\. They are unable to participate in English

Exclusion

    Key Trial Info

    Start Date :

    August 4 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2029

    Estimated Enrollment :

    320 Patients enrolled

    Trial Details

    Trial ID

    NCT06501365

    Start Date

    August 4 2025

    End Date

    December 31 2029

    Last Update

    August 27 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    UPMC/University of Pittsburgh

    Pittsburgh, Pennsylvania, United States, 15213